Agenus reported $2.95M in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agenus AGEN:US USD 2.95M 120K
AstraZeneca AZN:LN USD 387M 0
Celldex Therapeutics CLDX:US USD 47K 0
Glaxosmithkline GSK:US GBP 1.35B 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Immunogen IMGN:US USD 2.21M 2K
Jiangsu Hengrui Me. 600276:CH CNY 6.38B 0
Karyopharm Therapeutics KPTI:US USD 8K 0
Macrogenics MGNX:US USD 615K 0
Merck MRK:GR EUR 565M 0
Northwest Biotherapeutics NWBO:US USD 1.05M 17K
Novartis NOVN:VX USD 890M 0
Novavax NVAX:US USD 792K 4K
Regeneron Pharmaceuticals REGN:US USD 100K 0
Rigel Pharmaceuticals RIGL:US USD 173K 0
Sangamo Biosciences SGMO:US USD 1.62M 85K
Veracyte VCYT:US USD 72K 0